
In a regulatory filing, Apollo Hospitals stated that its board had approved AHLβs acquisition of 11.2% of Keimedβs issued and paid-up share capital in two tranches. The purchase will be made from Shobana Kamineni, a related party, for Rs 625.43 crore.
Additionally, AHL will invest Rs 99.99 crore in Keimed as a primary investment, as per the terms of a framework agreement executed among AHL, Keimed, and Keimedβs shareholders.
Also Read: Stocks in news: Adani Green, Adani Enterprises, NCC, Godrej Properties, Max Healthcare
Apollo Hospitals Q3 earnings
Apollo Hospitals reported a 52% year-on-year (YoY) increase in its consolidated net profit, reaching Rs 372 crore for the December 2024 quarter, driven by higher sales. The company had posted a net profit of Rs 245 crore in the same period of the previous fiscal year.
Also Read:Can Bitcoin drop to $20K if Nasdaq falls into a bear market?
Apollo Hospitals shares target price
As per Trendlyne data, the average target price of the stock is Rs 7,814, which shows an upside of 18% from the current market prices. The consensus recommendation from 29 analysts for the stock is a βBuyβ.
Technically, the stockβs relative strength index (RSI) is at 63.3. According to Trendlyne, an RSI below 30 is considered oversold, while above 70 indicates overbought conditions. Additionally, the MACD is at -101.1, which is below its center line, this is a bearish indicator.
Apollo Hospitals shares are trading above their 5-day, 10-day, 20-day, 30-day, and 50-day simple moving averages (SMAs) but remain below the 100-day, 150-day, and 200-day SMAs.
Apollo Hospitals shares performance
On Friday, Apollo Hospitals shares closed at Rs 6,621.5, rising 2.3% on the BSE, while the benchmark Sensex gained 0.73%. The stock has declined 10% year-to-date but gained 55% over the last two years. The companyβs market capitalization stands at Rs 95,207 crore.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)

Source link